IRON - NASDAQ

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%

HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.69B

EPS-6.0100

P/E Ratio-11.71

Earnings Date08/06/2026

iron

Sales/Maturities of Investments

Last Annual Value

456.22M

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Disc Medicine, Inc. Competitors Analysis of Sales/Maturities of Investments

IRON · NASDAQ

Company	Sales/Maturities of Investments	CAGR 3Y	CAGR 5Y	CAGR 10Y
Disc Medicine, Inc. NASDAQ:IRON	456.22M	N/A	N/A	N/A
Tarsus Pharmaceuticals, Inc. NASDAQ:TARS	361.80M	27.4%	N/A	N/A
Celcuity Inc. NASDAQ:CELC	332.51M	2.4%	N/A	N/A
CG Oncology, Inc. Common stock NASDAQ:CGON	844.14M	28.7%	N/A	N/A
Apogee Therapeutics, Inc. NASDAQ:APGE	467.87M	149.8%	N/A	N/A
Adaptive Biotechnologies Corporation NASDAQ:ADPT	222.62M	-26.9%	-16.8%	N/A
Legend Biotech Corporation NASDAQ:LEGN	5.33B	1.7%	87.5%	N/A
Scholar Rock Holding Corporation NASDAQ:SRRK	317.30M	-1.5%	9.7%	N/A

Disc Medicine, Inc. Fair Value Envelope

IRON · NASDAQ

Our analysis suggests that IRON has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.35, this represents a potential HIDDEN relative to our calculated worth for Disc Medicine, Inc..

HIDDEN

Intrinsic Value

Current Price: $70.35

Related Guides

Blog Categories

Continue your IRON research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.